A2P Stock Overview
Provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for A2P from our risk checks.
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Synektik Spólka Akcyjna Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł49.95 |
| 52 Week High | zł56.60 |
| 52 Week Low | zł26.00 |
| Beta | 1.37 |
| 1 Month Change | -8.52% |
| 3 Month Change | 13.39% |
| 1 Year Change | 86.38% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 87.08% |
Recent News & Updates
Recent updates
Shareholder Returns
| A2P | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | 0.5% | -0.4% | -0.5% |
| 1Y | 86.4% | -0.7% | 15.5% |
Return vs Industry: A2P exceeded the German Healthcare Services industry which returned -0.7% over the past year.
Return vs Market: A2P exceeded the German Market which returned 15.5% over the past year.
Price Volatility
| A2P volatility | |
|---|---|
| A2P Average Weekly Movement | 7.4% |
| Healthcare Services Industry Average Movement | 5.5% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in DE Market | 12.0% |
| 10% least volatile stocks in DE Market | 2.8% |
Stable Share Price: A2P has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: A2P's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 164 | Cezary Kozanecki | www.synektik.com.pl |
Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as researches, produces, and sells radiopharmaceutical products used in diagnostics for oncology.
Synektik Spólka Akcyjna Fundamentals Summary
| A2P fundamental statistics | |
|---|---|
| Market cap | €430.17m |
| Earnings (TTM) | €19.86m |
| Revenue (TTM) | €133.05m |
21.7x
P/E Ratio3.2x
P/S RatioIs A2P overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A2P income statement (TTM) | |
|---|---|
| Revenue | zł556.63m |
| Cost of Revenue | zł452.26m |
| Gross Profit | zł104.37m |
| Other Expenses | zł21.27m |
| Earnings | zł83.10m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Jun 11, 2025
| Earnings per share (EPS) | 9.74 |
| Gross Margin | 18.75% |
| Net Profit Margin | 14.93% |
| Debt/Equity Ratio | 0% |
How did A2P perform over the long term?
See historical performance and comparisonDividends
3.9%
Current Dividend Yield85%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/16 18:49 |
| End of Day Share Price | 2025/03/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Synektik Spólka Akcyjna is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kamil Kliszcz | Biuro maklerskie mBanku |
| Mateusz Krupa | Biuro maklerskie mBanku |
| Adrian Kowollik | East Value Research GmbH |